Kronos Bio revenue was $9.85M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $2.3M, down 4.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KRON annual revenue was $9.8M, with 56.6% growth year-over-year.
KRON past revenue growth
How has KRON's revenue growth performed historically?
On Invalid Date, Kronos Bio (NASDAQ: KRON) reported Q4 2024 revenue of $2.27 million up 0.7% year over year. In the same quarter last year, Kronos Bio's revenue was $2.29 million.
What was Kronos Bio's revenue in 2024?
Kronos Bio's annual revenue for the twelve months ending Dec 31, 2024 was $9.85 million, a 56.62% increase year over year.
How much does Kronos Bio make in a day?
Based on Kronos Bio annual revenue for the past five years, KRON makes an average of $8,841.64 per day.
What was Kronos Bio's annual revenue growth in the past year?
As of Q2 2025, Kronos Bio's revenue has grown 56.62% year over year. This is 441.08 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Kronos Bio's revenue in the past year totaled $9.85 million.
How much does Kronos Bio make in a year?
Kronos Bio's revenue by year for the past five years is:
Kronos Bio's revenue for the twelve months ending Dec 31, 2024 was $9.85 million, a 56.62% increase year over year.
Kronos Bio's annual revenue for Dec 31, 2023 was $6.29 million, a Infinity% increase from 2022.
Kronos Bio's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Kronos Bio's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Kronos Bio's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.